Shanghai Kaibao Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000JZ3
CNY
6.52
0.05 (0.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shanghai Kaibao Pharmaceutical Co., Ltd.
Why is Shanghai Kaibao Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.31% and Operating profit at 12.48% over the last 5 years
2
Negative results in Mar 25
  • INTEREST(9M) At CNY 0.04 MM has Grown at inf%
  • OPERATING CASH FLOW(Y) Lowest at CNY 334.96 MM
  • INTEREST COVERAGE RATIO(Q) Lowest at 420,999.44
3
Below par performance in long term as well as near term
  • Along with generating -8.52% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Kaibao Pharmaceutical Co., Ltd. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Shanghai Kaibao Pharmaceutical Co., Ltd.
-4.12%
0.41
34.32%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
2.31%
EBIT Growth (5y)
12.48%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.37
Tax Ratio
15.03%
Dividend Payout Ratio
27.85%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.20%
ROE (avg)
6.40%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.50
EV to EBIT
13.76
EV to EBITDA
12.38
EV to Capital Employed
1.91
EV to Sales
3.63
PEG Ratio
18.24
Dividend Yield
1.64%
ROCE (Latest)
13.90%
ROE (Latest)
8.22%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
ROCE(HY)

Highest at 9.3%

RAW MATERIAL COST(Y)

Fallen by -1.27% (YoY

-16What is not working for the Company
INTEREST(9M)

At CNY 0.04 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Lowest at CNY 334.96 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 420,999.44

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.6%

NET SALES(Q)

Fallen at -15.54%

Here's what is working for Shanghai Kaibao Pharmaceutical Co., Ltd.
Raw Material Cost
Fallen by -1.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Kaibao Pharmaceutical Co., Ltd.
Interest
At CNY 0.04 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 420,999.44
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow
Lowest at CNY 334.96 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
Fallen at -15.54%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Inventory Turnover Ratio
Lowest at 1.6%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio